https://www.selleckchem.com/pr....oducts/enfortumab-ve
Ten participants have had deep brain stimulator for their movement disorder, and all indicated positive effects. GNAO1-related neurodevelopmental disorders most often present within the first year of life with nonspecific symptoms of hypotonia or developmental delay. Although associated epilepsy and movement disorders can be severe, GNAO1-associated epilepsy may not always be medically refractory or lifelong. GNAO1-related neurodevelopmental disorders most often present within the first year of life with nonspecific symp